Literature DB >> 22043016

Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape.

Bao Hoa Duong1, Takayuki Ota, Miyo Aoki-Ota, Anthony Byron Cooper, Djemel Ait-Azzouzene, José Luis Vela, Amanda Lee Gavin, David Nemazee.   

Abstract

To analyze B lymphocyte central tolerance in a polyclonal immune system, mice were engineered to express a superantigen reactive to IgM of allotype b (IgM(b)). IgM(b/b) mice carrying superantigen were severely B cell lymphopenic, but small numbers of B cells matured. Their sera contained low levels of IgG and occasionally high levels of IgA. In bone marrow, immature B cells were normal in number, but internalized IgM and had a unique gene expression profile, compared with those expressing high levels of surface IgM, including elevated recombinase activator gene expression. A comparable B cell population was defined in wild-type bone marrows, with an abundance suggesting that at steady state ∼20% of normal developing B cells are constantly encountering autoantigens in situ. In superantigen-expressing mice, as well as in mice carrying the 3H9 anti-DNA IgH transgene, or 3H9 H along with mutation in the murine κ-deleting element RS, IgM internalization was correlated with CD19 downmodulation. CD19(low) bone marrow cells from 3H9;RS(-/-) mice were enriched in L chains that promote DNA binding. Our results suggest that central tolerance and attendant L chain receptor editing affect a large fraction of normal developing B cells. IgH(a/b) mice carrying the superantigen had a ∼50% loss in follicular B cell numbers, suggesting that escape from central tolerance by receptor editing from one IgH allele to another was not a major mechanism. IgM(b) superantigen hosts reconstituted with experimental bone marrow were demonstrated to be useful in revealing pathways involved in central tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22043016      PMCID: PMC3227399          DOI: 10.4049/jimmunol.1102479

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Contribution of receptor editing to the antibody repertoire.

Authors:  R Casellas; T A Shih; M Kleinewietfeld; J Rakonjac; D Nemazee; K Rajewsky; M C Nussenzweig
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

3.  Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice.

Authors:  D Melamed; E Miri; N Leider; D Nemazee
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 4.  Antibody regulation of B cell development.

Authors:  E Meffre; R Casellas; M C Nussenzweig
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

5.  IgA production without mu or delta chain expression in developing B cells.

Authors:  A J Macpherson; A Lamarre; K McCoy; G R Harriman; B Odermatt; G Dougan; H Hengartner; R M Zinkernagel
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

6.  Antibody repertoires generated by VH replacement and direct VH to JH joining.

Authors:  Sergei B Koralov; Tatiana I Novobrantseva; Jessica Königsmann; Andreas Ehlich; Klaus Rajewsky
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 7.  Receptor editing in lymphocyte development and central tolerance.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2006-10       Impact factor: 53.106

8.  Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.

Authors:  Renren Wen; Yuhong Chen; Li Bai; Guoping Fu; James Schuman; Xuezhi Dai; Hu Zeng; Chunying Yang; Robert P Stephan; John L Cleveland; Demin Wang
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

9.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

10.  Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice.

Authors:  T L Carvalho; T Mota-Santos; A Cumano; J Demengeot; P Vieira
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  18 in total

Review 1.  MicroRNA control of B cell tolerance, autoimmunity and cancer.

Authors:  Changchun Xiao; David Nemazee; Alicia Gonzalez-Martin
Journal:  Semin Cancer Biol       Date:  2020-08       Impact factor: 15.707

2.  Skewed primary Igκ repertoire and V-J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing.

Authors:  Miyo Aoki-Ota; Ali Torkamani; Takayuki Ota; Nicholas Schork; David Nemazee
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

3.  Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies.

Authors:  Lenka S Teodorovic; Chiara Babolin; Sarah L Rowland; Sarah A Greaves; David P Baldwin; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 4.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

Review 5.  miRNAs in B Cell Development and Lymphomagenesis.

Authors:  Maryaline Coffre; Sergei B Koralov
Journal:  Trends Mol Med       Date:  2017-07-07       Impact factor: 11.951

Review 6.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

Review 7.  Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity?

Authors:  Roberta Pelanda
Journal:  Curr Opin Immunol       Date:  2014-02-15       Impact factor: 7.486

8.  Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.

Authors:  Colleen Doyle-Cooper; Krystalyn E Hudson; Anthony B Cooper; Takayuki Ota; Patrick Skog; Phillip E Dawson; Michael B Zwick; William R Schief; Dennis R Burton; David Nemazee
Journal:  J Immunol       Date:  2013-08-12       Impact factor: 5.422

9.  Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-mice.

Authors:  Thiago Alves da Costa; Jacob N Peterson; Julie Lang; Jeremy Shulman; Xiayuan Liang; Brian M Freed; Susan A Boackle; Pilar Lauzurica; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

Review 10.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.